Phoenix Biotech Acquisition Corp. (PBAX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 24.74M |
| Enterprise Value | 23.78M |
| P/E Ratio | -0.26 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -18.17 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.25 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -43.52 |
| Return On Equity | 18.38 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 1.09M |
| Net Income | -95.53M |
| Diluted EPS | -22.58 |
| Total Cash | 857,489 |
| Total Cash/Share | 0.03 |
| Total Debt | 598,345 |
| Total Debt/Equity | -0.06 |
| Current Ratio | 0.14 |
| Book Value Per Share | -0.32 |
| 52-Week Change | -45.22 |
| 52-Week High | 12.8 |
| 52-Week Low | 4.12 |
| Moving Average 50 Days | 10.39 |
| Moving Average 200 Days | 10.74 |
| Average Volume | 8,080 |
| Shares Outstanding | 6.23M |
| % Held by Institutions | 0.08 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |